Discovery of potent and orally available small molecule inhibitors of the SOS1-KRAS interaction

被引：0
|
作者：
Yu, Ha Na
Ki, Dong Hyuk
Nam, Joonwoo
Kim, Eun-Jung
Kim, Sungeun
Choi, Hunmi
Kim, Jieun
Yu, Jihyun
Kim, Donggeon
Park, Dohyun
Yoon, Kyeong Jin
Jo, Seongin
Hwang, So-Hyeon
Lim, Sang Kyun
Shin, Young Sook
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of a potent, selective, and orally available small molecule for disruption of the SOS1-RAS interaction
    Ki, Dong Hyuk
    Yu, Hana
    Kim, Donggeon
    Jeon, Yeejin
    Jo, Seongin
    Nam, Joonwoo
    Kim, Eun-Jung
    Kim, Sungeun
    Choi, Hunmi
    Kim, Jieun
    Yu, Jihyun
    Choi, Sungpil
    Han, Wooseok
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Discovery of potent, orally bioavailable, SOS1 inhibitors for KRAS-driven tumors.
    Sasmal, Sanjita
    Patra, Sukanya
    Boorgu, Venkatesham
    Yanamadra, Mahesh
    Ettam, Ashok
    Dunaboyina, Nagaraju
    Kummari, Githavani
    Yengala, Ram Mohan
    Lakhavath, Balakrishna
    Das, Jayita
    Sunkanapally, Satheesh
    Reddy, Pravalika
    Mathew, Megha Mariam
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma
    He, Huan
    Zhang, Yu
    Xu, Juan
    Li, Yuanyuan
    Fang, Huaxiang
    Liu, Yi
    Zhang, Silong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (19) : 13158 - 13171
  • [4] BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
    Hofmann, Marco H.
    Gmachl, Michael
    Ramharter, Juergen
    Savarese, Fabio
    Gerlach, Daniel
    Marszalek, Joseph R.
    Sanderson, Michael P.
    Kessler, Dirk
    Trapani, Francesca
    Arnhof, Heribert
    Rumpel, Klaus
    Botesteanu, Dana-Adriana
    Ettmayer, Peter
    Gerstberger, Thomas
    Kofink, Christiane
    Wunberg, Tobias
    Zoephel, Andreas
    Fu, Szu-Chin
    Teh, Jessica L.
    Boettcher, Jark
    Pototschnig, Nikolai
    Schachinger, Franziska
    Schipany, Katharina
    Lieb, Simone
    Vellano, Christopher P.
    O'Connell, Jonathan C.
    Mendes, Rachel L.
    Moll, Jurgen
    Petronczki, Mark
    Heffernan, Timothy P.
    Pearson, Mark
    McConnell, Darryl B.
    Kraut, Norbert
    CANCER DISCOVERY, 2021, 11 (01) : 142 - 157
  • [5] Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS-SOS1 Interaction
    Ikram, Saima
    Sayyah, Ehsan
    Durdagi, Serdar
    CHEMBIOCHEM, 2024, 25 (12)
  • [6] Discovery of orally available and highly efficacious small molecule BACE inhibitors for Alzheimer's disease
    Zhong, Wenge
    Brown, Jim
    Brown, Ryan
    Cheng, Yuan
    Croghan, Michael
    Dineen, Tom
    Graceffa, Russell
    Harried, Scott
    Hitchcock, Stephen
    Horne, Daniel
    Huang, Hongbing
    Hungate, Randall W.
    Imbeah-Ampiah, Ronke
    Judd, Ted
    Kaller, Matt
    Kreiman, Chuck
    La, Dan
    Lopez, Patricia
    Monenschein, Holger
    Nguyen, Tom
    Patel, Vinod
    Pennington, Lew
    Weiss, Matt
    Xue, May
    Yang, Bryant
    Albrecht, Brian
    Masse, Craig
    Bartberger, Michael
    Jordan, Steven
    Hansen, Karl
    Tedrow, Jason
    Dunn, Robert
    Vargas, Hugo
    Williamson, Toni
    Fremeau, Robert
    Treanor, James
    Kiang, Yuan-Hon
    Hickman, Dean
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [7] Discovery of novel, potent and orally available MAT2A inhibitors
    Chen, Xuxing
    Li, Jing
    Chen, Yanhong
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Discovery of GSBR-1290, a Highly Potent, Orally Available, Novel Small Molecule GLP-1 Receptor Agonist
    Mao, Ting
    Meng, Qinghua
    Zhang, Haizhen
    Zhang, Jinqiang J.
    Shi, Songting
    Guan, Zhibo
    Jiang, Xinglong
    Zhang, Fang
    Lei, Hui
    Lin, Xichen
    DIABETES, 2023, 72
  • [9] Discovery of Nonpeptide, Orally Available Small Molecule GLP-1 Receptor Agonists
    Im, A-Rang
    Park, Jung-Eun
    Hong, Dahae
    Je, In-Gyu
    Kim, Jung Ho
    Chang, Min Whan
    Hong, Chang-Hee
    Shin, Jae Eui
    Sohn, Te-Ik
    Jun, Yearin
    Jang, Eunhye
    Yoo, Yeongran
    Jeon, Woojin
    An, Kyungmi
    DIABETES, 2021, 70
  • [10] Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor
    Doyon, Julien
    Coesemans, Erwin
    Boeckx, Staf
    Buntinx, Mieke
    Hermans, Bart
    Van Wauwe, Jean P.
    Gilissen, Ron A. H. J.
    De Groot, Alex H. J.
    Corens, David
    Van Lommen, Guy
    CHEMMEDCHEM, 2008, 3 (04) : 660 - 669
12345